Does estrogen receptor gene polymorphism play a role in Parkinson's disease?

Biomedicine and Pharmacotherapy

Volumn 63, Issue 8, 2009, Pages 599-602

  Li, Xue Li ^a   Cheng, Wei Dong ^a   Li, Juan ^a   Zheng, Yu Feng ^a   Guo, Cun Ju ^a   Sun, Sheng Gang ^b   Wang, Le Xin ^c  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Estrogen; Gene polymorphisms; Neurology; Parkinson's disease; Receptor

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN;

EID: 70349337883     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.09.007     Document Type: Article

References (14)

1. Tanner C.M., Chen B., Wang W., Peng M., Liu Z., Liang X., et al. Environmental factors and Parkinson's disease: a case-control study in China. Neurology 39 3 (1989) 660-664
2. Liu L.X., Chen W.F., Xie J.X., and Wong M.S. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Neurosci Res 60 2 (2008) 156-161
3. Ohtani H., Nomoto M., and Douchi T. Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats. Brain Res 900 (2001) 163-168
4. Tripanichkul W., Jaroensuppaperch E.O., and Finkelstein D.I. Estrogen enhances the number of nigral dopaminergic neurons of adult male mice without affecting nigral neuroglial number and morphology. Neurosci Lett 25 435 (2008) 210-214
5. +, oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem 76 (2001) 1010-1021
6. Westberg L., Håkansson A., and Melke J. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 29 8 (2004) 993-998
7. Dhandapani K.M., and Brann D.W. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 67 5 (2002) 1379-1385
8. Håkansson A., Westberg L., and Nilsson S. Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease. Neuropsychiatr Genet 133 1 (2005) 88-92
9. Kobayashi S., Inoue S., and Hosoi T. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11 (1996) 306-311
10. Isoe-Wada K., Maeda M., and Yong J. Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. Eur J Neurol 6 4 (1999) 431-435
11. Maraganore D.M., Farrer M.J., and McDonnell S.K. Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease. Mov Disord 17 3 (2002) 509-512
12. Mattila K.M., Rinne J.O., and Roytta M. Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia. Acta Neurol Scand 106 3 (2002) 128-130
13. Sawada H., Ibi H., and Kihara T. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress induced neuronal death. J Neurosci Res 54 5 (1998) 707-719
14. Carling T., Rastad J., and Kindmaek A. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery 122 (1997) 101-106